Loading...

QSAM Biosciences, Inc.

QSAM•PNK
Healthcare
Biotechnology
$8.30
$-16591.70(-99.95%)

QSAM Biosciences, Inc. (QSAM) Stock Overview

Explore QSAM Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap18.4K
P/E Ratio-0.00
EPS (TTM)$-1.69
ROE16.18%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

QSAM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of QSAM Biosciences, Inc. (QSAM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 18.4K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for QSAMStats details for QSAM are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for QSAMAnalyst Recommendations details for QSAM are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage bone targeting radiopharmaceutical. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was incorporated in 2004 and is headquartered in Austin, Texas.

CEO

Douglas R. Baum

Employees

4

Headquarters

Plaza 1, Austin, TX

Founded

2012

Frequently Asked Questions

;